Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase

被引:58
作者
Hughes, BW
King, SA
Allan, PW
Parker, WB
Sorscher, EJ
机构
[1] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
[3] So Res Inst, Birmingham, AL 35255 USA
关键词
D O I
10.1074/jbc.273.4.2322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of Escherichia coli purine nucleoside phosphorylase (PNP) activates prodrugs and kills entire populations of mammalian cells, even when as few as 1% of the cells express this gene. This phenomenon of bystander billing has been previously investigated for herpes simplex virus-thymidine kinase (HSV-TR) and has been shown to require cell to cell contact. Using silicon rings to separate E. coli PNP expressing cells from non-expressing cells sharing the same medium, we demonstrate that bystander cell killing by E. coli PNP does not require cell-cell contact. Initially, cells expressing E. coli PNP convert the non-toxic prodrug, 6-methylpurine-2'-deoxyriboside (MeP-dR) to the highly toxic membrane permeable toxin, 6-methylpurine (MeP). As the expressing cells die, E. coli PNP is released into the culture medium, retains activity, and continues precursor conversion extracellularly (as determined by reverse phase high performance liquid chromatography of both prodrug and toxin). Bystander killing can also be observed in the absence of extracellular E. coli PNP by removing the MeP-dR prior to death of the expressing cells. In this case, 100% of cultured cells die when as few as 3% of the cells of a population express E. coli PNP. Blocking nucleoside transport with nitrobenzylthioinosine reduces MeP-dR mediated cell killing but not MeP cell killing. These mechanisms differ fundamentally from those previously reported for the HSV-TK gene.
引用
收藏
页码:2322 / 2328
页数:7
相关论文
共 26 条
[1]  
Allan P. W., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P379
[2]   The thymidine kinase ganciclovir-mediated ''suicide'' effect is variable in different tumor cells [J].
Beck, C ;
Cayeux, S ;
Lupton, SD ;
Dorken, B ;
Blankenstein, T .
HUMAN GENE THERAPY, 1995, 6 (12) :1525-1530
[3]   HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia [J].
Bonini, C ;
Ferrari, G ;
Verzeletti, S ;
Servida, P ;
Zappone, E ;
Ruggieri, L ;
Ponzoni, M ;
Rossini, S ;
Mavilio, F ;
Traversari, C ;
Bordignon, C .
SCIENCE, 1997, 276 (5319) :1719-1724
[4]  
BOTH GW, 1997, MOL CELLULAR BIOL GE, P26
[5]   Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma [J].
Caruso, M ;
PhamNguyen, K ;
Kwong, YL ;
Xu, BS ;
Kosai, KI ;
Finegold, M ;
Woo, SLC ;
Chen, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11302-11306
[6]   ADENOVIRUS-MEDIATED TRANSFER OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION FOLLOWING BALLOON ANGIOPLASTY OF THE RAT CAROTID-ARTERY [J].
CHANG, MW ;
OHNO, T ;
GORDON, D ;
LU, MM ;
NABEL, GJ ;
NABEL, EG ;
LEIDEN, JM .
MOLECULAR MEDICINE, 1995, 1 (02) :172-181
[7]  
Connors TA, 1995, GENE THER, V2, P702
[8]   Converting cancer genes into killer genes [J].
DaCosta, LT ;
Jen, J ;
He, TC ;
Chan, TA ;
Kinzler, KW ;
Vogelstein, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4192-4196
[9]  
DENNIG CN, 1997, MOL CELLULAR BIOL GE
[10]  
Freeman SM, 1996, SEMIN ONCOL, V23, P31